Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6701565 | 0.67 | ALDH1A1 (0.32) | TRPA1 | |
| SCHEMBL6701570 | 0.67 | ALDH1A1 (0.32) | TRPA1 | |
| Hydrochloric Acid SCHEMBL9675136 | 0.65 | — | — | |
| SCHEMBL1697371 | 0.64 | TAS2R38 (0.30) | — | |
| SCHEMBL12562484 | 0.64 | TAS2R38 (0.30) | — | |
| SCHEMBL19968214 | 0.64 | TAS2R38 (0.30) | — | |
| SCHEMBL1872465 | 0.61 | CYP2D6 (0.37) | — | |
| SCHEMBL5444883 | 0.61 | — | — | |
| SCHEMBL24288682 | 0.60 | — | — | |
| SCHEMBL20332448 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10207262-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | OXER1, LIG1, PICALM | TRPA1 1838/4885 |
| US-10207262-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | TRPA1 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.